Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D001479:Basal Ganglia / Q000032:analysis; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D002540:Cerebral Cortex / Q000032:analysis; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004744:Enkephalin, Methionine / Q000378:metabolism; D019835:FMRFamide; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009454:Neurofibrils / Q000473:pathology; D009478:Neuropeptide Y; D009496:Neurotensin / Q000378:metabolism; D009842:Oligopeptides / Q000378:metabolism; D010455:Peptides / Q000032:analysis* / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000032:analysis
D009419:Nerve Tissue Proteins; D009478:Neuropeptide Y; D009842:Oligopeptides; D010455:Peptides; C029993:somatostatin-like peptides; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D009496:Neurotensin; D005680:gamma-Aminobutyric Acid; D004744:Enkephalin, Methionine; D019835:FMRFamide; D014446:Tyrosine 3-Monooxygenase; D002795:Choline O-Acetyltransferase; D005968:Glutamate Decarboxylase